JP6530753B2 - イソオキサゾリン化合物の抗寄生生物薬使用 - Google Patents

イソオキサゾリン化合物の抗寄生生物薬使用 Download PDF

Info

Publication number
JP6530753B2
JP6530753B2 JP2016537438A JP2016537438A JP6530753B2 JP 6530753 B2 JP6530753 B2 JP 6530753B2 JP 2016537438 A JP2016537438 A JP 2016537438A JP 2016537438 A JP2016537438 A JP 2016537438A JP 6530753 B2 JP6530753 B2 JP 6530753B2
Authority
JP
Japan
Prior art keywords
fleas
isoxazoline compound
flea
compound
isoxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016537438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539960A5 (enExample
JP2016539960A (ja
Inventor
ウイリアムズ,ハイケ
ゾラー,ハルトムート
ヘツカロス,アンニヤ・レギーナ
Original Assignee
インターベット インターナショナル ベー. フェー.
インターベット インターナショナル ベー. フェー.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49759099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6530753(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by インターベット インターナショナル ベー. フェー., インターベット インターナショナル ベー. フェー. filed Critical インターベット インターナショナル ベー. フェー.
Publication of JP2016539960A publication Critical patent/JP2016539960A/ja
Publication of JP2016539960A5 publication Critical patent/JP2016539960A5/ja
Application granted granted Critical
Publication of JP6530753B2 publication Critical patent/JP6530753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2016537438A 2013-12-10 2014-12-09 イソオキサゾリン化合物の抗寄生生物薬使用 Active JP6530753B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13196539 2013-12-10
EP13196539.4 2013-12-10
PCT/EP2014/076959 WO2015086551A1 (en) 2013-12-10 2014-12-09 Antiparasitic use of isoxazoline compounds

Publications (3)

Publication Number Publication Date
JP2016539960A JP2016539960A (ja) 2016-12-22
JP2016539960A5 JP2016539960A5 (enExample) 2018-01-25
JP6530753B2 true JP6530753B2 (ja) 2019-06-12

Family

ID=49759099

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016537438A Active JP6530753B2 (ja) 2013-12-10 2014-12-09 イソオキサゾリン化合物の抗寄生生物薬使用

Country Status (14)

Country Link
US (1) US9655884B2 (enExample)
EP (1) EP3079474B1 (enExample)
JP (1) JP6530753B2 (enExample)
CN (1) CN105992517B (enExample)
AU (1) AU2014363695B2 (enExample)
BR (1) BR112016013020B1 (enExample)
CA (1) CA2932790C (enExample)
DK (1) DK3079474T3 (enExample)
ES (1) ES2742815T3 (enExample)
HU (1) HUE046067T2 (enExample)
PL (1) PL3079474T3 (enExample)
PT (1) PT3079474T (enExample)
RU (1) RU2673723C1 (enExample)
WO (1) WO2015086551A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017027855B1 (pt) 2015-06-23 2022-11-16 Intervet International B.V. Composição farmacêutica, seu uso, água potável medicamentosa e método para sua preparação
CN107535510A (zh) * 2017-09-29 2018-01-05 北京科发伟业农药技术中心 一种含fluralaner的组合物
EP3723483B1 (en) 2017-12-12 2025-09-03 Intervet International B.V. Implantable fluralaner pharmaceutical compositions and uses thereof
BR112022000982A2 (pt) 2019-07-22 2022-03-08 Intervet Int Bv Forma de dosagem veterinária mastigável macia
EP4075981A1 (en) * 2019-12-16 2022-10-26 Intervet International B.V. Composition for lice control
US12497370B2 (en) 2019-12-18 2025-12-16 Elanco Tiergesundheit Ag Isoxazoline derivatives
US12655138B2 (en) 2020-07-24 2026-06-16 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
WO2022192623A1 (en) * 2021-03-11 2022-09-15 In The Bowl Animal Health, Inc. Oral canine feed and methods for controlling flea infestations in a canine
WO2022271961A1 (en) * 2021-06-25 2022-12-29 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling tick infestations in a feline
DK182016B1 (en) 2023-03-13 2025-05-28 Zoetis Services Llc Degradation of isoxazolines in ozonated sea water

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001100A1 (en) 1982-09-17 1984-03-29 Edward Ireland Improved dental matrix band
BR9710910A (pt) * 1996-08-02 1999-08-17 Novartis Ag Processo aperfei-oado para administra-Æo sist-mica de inseticidas do tipo cido 2,4-dienÄico a mamiferos terrestres
PT1119256E (pt) * 1998-10-09 2003-10-31 Novartis Ag Combinacao oral de lufenurao e nitenpiram contra as pulgas
EP1671941A4 (en) 2003-09-30 2007-12-12 Nissan Chemical Ind Ltd SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
TWI412322B (zh) 2005-12-30 2013-10-21 杜邦股份有限公司 控制無脊椎害蟲之異唑啉
EP2151437A4 (en) 2007-03-07 2012-05-02 Nissan Chemical Ind Ltd ISOXAZOLINE SUBSTITUTED BENZAMIDE COMPOUND AND PEST CONTROL AGENT
DE102007028871A1 (de) 2007-06-22 2008-12-24 Clariant International Limited Verfahren zur Herstellung von reinem C.I. Pigment Orange 74
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2182945T3 (en) 2007-06-27 2015-11-16 Du Pont PROCEDURE TO COMBAT PESTS WITH ANIMALS
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
AR074790A1 (es) 2008-12-19 2011-02-09 Novartis Ag Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente.
AP2014007874A0 (en) 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
CN108685894B (zh) 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品

Also Published As

Publication number Publication date
PL3079474T3 (pl) 2019-10-31
BR112016013020A2 (pt) 2017-08-08
BR112016013020B1 (pt) 2020-12-01
RU2673723C1 (ru) 2018-11-29
HUE046067T2 (hu) 2020-02-28
EP3079474A1 (en) 2016-10-19
PT3079474T (pt) 2019-09-10
US20160303086A1 (en) 2016-10-20
JP2016539960A (ja) 2016-12-22
EP3079474B1 (en) 2019-07-03
CA2932790A1 (en) 2015-06-18
DK3079474T3 (da) 2019-09-16
AU2014363695A1 (en) 2016-06-09
CN105992517B (zh) 2020-03-06
US9655884B2 (en) 2017-05-23
AU2014363695B2 (en) 2018-12-13
CN105992517A (zh) 2016-10-05
CA2932790C (en) 2021-10-12
ES2742815T3 (es) 2020-02-17
WO2015086551A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
CN105992517B (zh) 异噁唑啉化合物的抗寄生虫用途
US12128032B2 (en) Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
US20200000718A1 (en) Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds
WO2021122515A1 (en) Parasite control in ruminants
CN118593485B (zh) 异噁唑啉复合物及其组合物
RU2796536C2 (ru) Применение изоксазолиновых соединений на домашней птице
RU2796536C9 (ru) Применение изоксазолиновых соединений на домашней птице
US20240366572A1 (en) Isoxazoline complexes and compositions thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171207

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180828

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190405

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190423

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190517

R150 Certificate of patent or registration of utility model

Ref document number: 6530753

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250